KR102273481B1 - 사이클로스포린 및 멘톨 함유 나노 에멀젼 점안 조성물 및 그의 제조 방법 - Google Patents
사이클로스포린 및 멘톨 함유 나노 에멀젼 점안 조성물 및 그의 제조 방법 Download PDFInfo
- Publication number
- KR102273481B1 KR102273481B1 KR1020200113258A KR20200113258A KR102273481B1 KR 102273481 B1 KR102273481 B1 KR 102273481B1 KR 1020200113258 A KR1020200113258 A KR 1020200113258A KR 20200113258 A KR20200113258 A KR 20200113258A KR 102273481 B1 KR102273481 B1 KR 102273481B1
- Authority
- KR
- South Korea
- Prior art keywords
- nano
- castor oil
- cyclosporine
- less
- emulsion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020210085410A KR102638866B1 (ko) | 2019-09-09 | 2021-06-30 | 사이클로스포린 및 멘톨 함유 나노 에멀젼 점안 조성물 및 그의 제조 방법 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20190111776 | 2019-09-09 | ||
| KR1020190111776 | 2019-09-09 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020210085410A Division KR102638866B1 (ko) | 2019-09-09 | 2021-06-30 | 사이클로스포린 및 멘톨 함유 나노 에멀젼 점안 조성물 및 그의 제조 방법 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20210030215A KR20210030215A (ko) | 2021-03-17 |
| KR102273481B1 true KR102273481B1 (ko) | 2021-07-06 |
Family
ID=74867274
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020200113258A Active KR102273481B1 (ko) | 2019-09-09 | 2020-09-04 | 사이클로스포린 및 멘톨 함유 나노 에멀젼 점안 조성물 및 그의 제조 방법 |
| KR1020210085410A Active KR102638866B1 (ko) | 2019-09-09 | 2021-06-30 | 사이클로스포린 및 멘톨 함유 나노 에멀젼 점안 조성물 및 그의 제조 방법 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020210085410A Active KR102638866B1 (ko) | 2019-09-09 | 2021-06-30 | 사이클로스포린 및 멘톨 함유 나노 에멀젼 점안 조성물 및 그의 제조 방법 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US12576126B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4029493A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022548221A (cg-RX-API-DMAC7.html) |
| KR (2) | KR102273481B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN114364372A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3149270A1 (cg-RX-API-DMAC7.html) |
| PH (1) | PH12022550500A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021049825A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023190283A1 (ja) * | 2022-03-28 | 2023-10-05 | 中外製薬株式会社 | ポリオキシエチレン構造を含む油性成分を含有する化合物製剤 |
| IL294896B1 (en) * | 2022-07-20 | 2026-06-01 | LYOTROPIC DELIVERY SYSTEMS Ltd | Topical administration of cyclosporine to the eye |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009501228A (ja) | 2005-07-13 | 2009-01-15 | アラーガン、インコーポレイテッド | シクロスポリン組成物 |
| KR101492447B1 (ko) | 2013-05-20 | 2015-02-23 | 주식회사태준제약 | 사이클로스포린을 함유하는 나노에멀젼 점안 조성물 및 그의 제조 방법 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6635796B2 (en) | 1990-03-16 | 2003-10-21 | Sevenson Environmental Services, Inc. | Reduction of leachability and solubility of radionuclides and radioactive substances in contaminated soils and materials |
| KR0167613B1 (ko) | 1994-12-28 | 1999-01-15 | 한스 루돌프 하우스, 니콜 케르커 | 사이클로스포린-함유 연질캅셀제 조성물 |
| KR100336090B1 (ko) | 1998-06-27 | 2002-05-27 | 윤승원 | 오일, 지방산 또는 이들의 혼합물을 함유한 난용성 약물의 고형분산제제 |
| KR20020011985A (ko) * | 1999-05-07 | 2002-02-09 | 파르마솔 게엠베하 | 액상 및 고체상 지질 혼합물에 기초한 지질입자들 및 그의제조방법 |
| CA2426164C (en) | 2001-06-27 | 2009-08-11 | Nokia Corporation | Method and system for bearer authorization in a wireless communication network |
| AU2002357604A1 (en) | 2001-12-21 | 2003-07-09 | Senju Pharmaceutical Co., Ltd. | Eye drops |
| PT1487416E (pt) | 2002-03-26 | 2010-01-25 | Teva Pharma | Micropartículas de fármacos |
| CN1232539C (zh) | 2002-05-10 | 2005-12-21 | 刘云清 | 有机药物与倍他环糊精衍生物的配合物及其制备方法 |
| AU2004212989A1 (en) * | 2003-02-20 | 2004-09-02 | Teva Pharmaceutical Industries Ltd. | Menthol solutions of drugs |
| US20070008894A1 (en) | 2004-10-19 | 2007-01-11 | Idt Corporation | Telecommunications-based link monitoring system |
| US7202209B2 (en) | 2005-07-13 | 2007-04-10 | Allergan, Inc. | Cyclosporin compositions |
| KR100669510B1 (ko) | 2005-08-17 | 2007-01-16 | 보람제약주식회사 | 사이크로스포린을 함유한 나노 에멀젼 농축액 조성물 및 그제조방법 |
| CN101244256A (zh) * | 2007-02-16 | 2008-08-20 | 中国科学院上海药物研究所 | 一种环孢菌素a眼用微/亚微乳原位凝胶制剂及其制备方法 |
| EP3078385A1 (en) * | 2010-05-25 | 2016-10-12 | Allergan, Inc. | Cyclosporin emulsions |
| WO2012015211A2 (ko) * | 2010-07-30 | 2012-02-02 | 주식회사종근당 | 사이클로스포린 에이 함유 점안제 조성물 |
| KR20130100290A (ko) * | 2010-08-30 | 2013-09-10 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 협착성 병변을 위한 전단 제어 방출 및 혈전 용해 치료법 |
| US8455991B2 (en) | 2010-09-24 | 2013-06-04 | Stats Chippac Ltd. | Integrated circuit packaging system with warpage control and method of manufacture thereof |
| WO2013008714A1 (ja) * | 2011-07-08 | 2013-01-17 | ロート製薬株式会社 | 眼科用水性組成物 |
| KR101211902B1 (ko) | 2012-04-30 | 2012-12-13 | 주식회사 휴온스 | 사이클로스포린 함유 무자극성 나노에멀젼 안약 조성물 |
| US10963928B2 (en) | 2014-08-21 | 2021-03-30 | Stubhub, Inc. | Crowdsourcing seat quality in a venue |
| DK3006045T3 (en) * | 2014-10-07 | 2017-07-17 | Cyprumed Gmbh | Pharmaceutical formulations for oral administration of peptide or protein drugs |
| KR20170032808A (ko) * | 2015-09-15 | 2017-03-23 | 주식회사 엘지생활건강 | 멘톨 또는 멘톨 유도체를 포함하는 용해성 미세바늘 패치 |
| CN105726479B (zh) * | 2016-03-24 | 2018-06-22 | 北京茗泽中和药物研究有限公司 | 环孢素眼用乳剂 |
| CA3285799A1 (en) * | 2016-10-12 | 2025-11-29 | Ps Therapy, Inc. | Artificial tear, contact lens and drug vehicle compositions and methods of use thereof |
| US11583496B2 (en) * | 2016-10-12 | 2023-02-21 | PS Therapy Inc. | Drug vehicle compositions and methods of use thereof |
| WO2019111917A1 (ja) * | 2017-12-07 | 2019-06-13 | ライオン株式会社 | 水性眼科用組成物及びエマルション粒子の微粒化方法 |
| CN110090294A (zh) * | 2019-04-09 | 2019-08-06 | 嘉兴市爵拓科技有限公司 | 具有改善的干燥保护和保留的眼用组合物 |
-
2020
- 2020-09-04 EP EP20862827.1A patent/EP4029493A4/en active Pending
- 2020-09-04 PH PH1/2022/550500A patent/PH12022550500A1/en unknown
- 2020-09-04 US US17/641,793 patent/US12576126B2/en active Active
- 2020-09-04 CA CA3149270A patent/CA3149270A1/en active Pending
- 2020-09-04 KR KR1020200113258A patent/KR102273481B1/ko active Active
- 2020-09-04 CN CN202080062721.9A patent/CN114364372A/zh active Pending
- 2020-09-04 WO PCT/KR2020/011977 patent/WO2021049825A1/ko not_active Ceased
- 2020-09-04 JP JP2022515794A patent/JP2022548221A/ja active Pending
-
2021
- 2021-06-30 KR KR1020210085410A patent/KR102638866B1/ko active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009501228A (ja) | 2005-07-13 | 2009-01-15 | アラーガン、インコーポレイテッド | シクロスポリン組成物 |
| KR101492447B1 (ko) | 2013-05-20 | 2015-02-23 | 주식회사태준제약 | 사이클로스포린을 함유하는 나노에멀젼 점안 조성물 및 그의 제조 방법 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP4029493A4 (en) | 2023-10-04 |
| CN114364372A (zh) | 2022-04-15 |
| KR20210030215A (ko) | 2021-03-17 |
| WO2021049825A1 (ko) | 2021-03-18 |
| KR102638866B1 (ko) | 2024-02-21 |
| KR20210084389A (ko) | 2021-07-07 |
| EP4029493A1 (en) | 2022-07-20 |
| PH12022550500A1 (en) | 2023-10-18 |
| US20240041974A1 (en) | 2024-02-08 |
| JP2022548221A (ja) | 2022-11-17 |
| US12576126B2 (en) | 2026-03-17 |
| CA3149270A1 (en) | 2021-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102204221B1 (ko) | 사이클로스포린을 함유하는 나노에멀젼 점안 조성물 및 그의 제조 방법 | |
| EP2136782B1 (en) | Ophthalmic oil-in-water emulsions containing prostaglandins | |
| JP5441058B2 (ja) | 四級アンモニウム化合物を含む組成物 | |
| EP2968139B1 (en) | Microemulsion topical delivery platform | |
| WO2023103835A1 (zh) | 一种酪氨酸激酶抑制剂眼用制剂及其制备方法和用途 | |
| WO2021032073A1 (en) | In-situ gel containing cyclosporine micelles as sustained ophthalmic drug delivery system | |
| KR102638866B1 (ko) | 사이클로스포린 및 멘톨 함유 나노 에멀젼 점안 조성물 및 그의 제조 방법 | |
| RU2698456C2 (ru) | Офтальмологический гель биматопроста, который наносится в виде капель | |
| WO2018105681A1 (ja) | 眼科用組成物及びその製造方法 | |
| KR20150000405A (ko) | 난용성 의약품의 수중유적형 에멀젼 조성물 및 이의 제조방법 | |
| JP2002506808A (ja) | グリコーゲン含有眼用溶液 | |
| CN110022856B (zh) | 用于降低眼压的眼用组合物 | |
| DK3229780T3 (en) | Ophthalmic composition for use in the treatment of dry eye syndrome | |
| CN112839641A (zh) | 眼科用组合物 | |
| RU2634267C2 (ru) | Водный офтальмологический раствор на основе циклоспорина a | |
| KR101510764B1 (ko) | 사이클로스포린 함유 안약 조성물 및 그 제조방법 | |
| TW201836611A (zh) | 含有他氟前列素及檸檬酸酯之緩釋劑 | |
| US20240009124A1 (en) | Ophthalmic Suspension Base having a Micro-fluidized Positively Charged Nanoparticle | |
| JPH0273014A (ja) | 眼科用α―メチル―4―(2’―チエニルカルボニル)フェニル酢酸リジン液剤の製法 | |
| McCann | Advances and challenges in topical ocular medications | |
| HK40005358B (en) | Eye-drop composition for lowering intraocular pressure | |
| HK40005358A (en) | Eye-drop composition for lowering intraocular pressure | |
| HK1133598B (en) | Ophthalmic oil-in-water emulsions containing prostaglandins |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
St.27 status event code: A-0-1-A10-A12-nap-PA0109 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| PA0302 | Request for accelerated examination |
St.27 status event code: A-1-2-D10-D17-exm-PA0302 St.27 status event code: A-1-2-D10-D16-exm-PA0302 |
|
| D13-X000 | Search requested |
St.27 status event code: A-1-2-D10-D13-srh-X000 |
|
| D14-X000 | Search report completed |
St.27 status event code: A-1-2-D10-D14-srh-X000 |
|
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
| A107 | Divisional application of patent | ||
| GRNT | Written decision to grant | ||
| PA0107 | Divisional application |
St.27 status event code: A-0-1-A10-A18-div-PA0107 St.27 status event code: A-0-1-A10-A16-div-PA0107 |
|
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U11-oth-PR1002 Fee payment year number: 1 |
|
| PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 4 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 5 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 6 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE) Year of fee payment: 6 |